For AD, genetically predicted increased expression of LIAS was associated with elevated risk (OR: 1.046; 95% CI: 1.009–1.085; p = 0.015), implicating lipoic acid synthesis in AD pathogenesis. The gene discussed is LIAS; the disease is Alzheimer disease.